Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Pharma
Lilly touts winning tirzepatide data in prediabetes patients
Lilly on Wednesday laid out full results from its longest completed study of the dual GIP/GLP-1 receptor agonist tirzepatide to date.
Fraiser Kansteiner
Nov 13, 2024 5:01pm
MSF calls on Lilly, Novo and Sanofi to charge $1 per insulin pen
Nov 11, 2024 10:59am
Novo, Lilly lost value in Q3 while BMS, Gilead and Sanofi surged
Nov 8, 2024 5:00am
Amid a new MASH market, ‘tremendous change’ is on the horizon
Nov 5, 2024 10:02am
Novartis filed patent lawsuits in defense of radiopharma meds
Nov 4, 2024 10:48am
Incyte wins injunction to block Sun's Leqselvi launch
Nov 4, 2024 10:01am
